Sutro is in a precarious spot. Investors have all but ditched the company, currently valuing it at $78 million - less than ...

Dublin-based Aerska launched on Wednesday with $21 million in seed funding and a technology designed to shuttle RNA ...

What’s the closest thing to investing in a private equity healthcare fund, where a few big winners can make us forget that ...

IBB offers diversified exposure to the biotech sector, focusing on large-cap leaders while maintaining positions in smaller ...

Oncolytics Biotech shares rose after the company said it will meet with the Food and Drug Administration in November about advancing its treatment for pancreatic cancer to a clinical trial. The stock ...

The CUTX-101 NDA was initially granted Priority Review by the FDA and is supported by positive topline clinical efficacy results for CUTX-101, demonstrating significant improvement in overall survival ...

Weight loss drugs have represented an enormous growth area for biotech and pharma companies over the past couple of years.

The biotech industry is almost always buzzing. However, there has been some unanticipated activity in this sector of late.

Dire wolves — an animal that went extinct 13,000 years ago — that were born with the help of a Texas biotech company ...

The share of U.S. startup investment going to biotech companies has hit the lowest level in more than 20 years, as an ever-growing proportion of funding goes to AI upstarts in other sectors. We take a ...

Colossal Biosciences opens global HQ with 100 scientists focused on "de-extinction," using CRISPR to revive species like the ...

Join us for Bisnow's 2025 Boston Biotech Summit to learn from the city's top life sciences companies, developers, investors ...